XML 38 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 1 - Summary of Significant Interim Accounting Policies (Tables)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]  
   
Three Months
Ended September 30,
   
Nine Months
Ended September 30,
 
   
2012
   
2011
   
2012
   
2011
 
Net earnings used in the computation of basic and diluted earnings per share
  $ 1,242,000     $
1,880,000
    $ 2,546,000     $ 3,411,000  
                                 
Weighted average shares outstanding - basic
    6,063,269       5,986,676       6,051,795       5,986,884  
Common stock equivalents
    84,743       92,754       92,076       93,956  
Weighted average shares outstanding - diluted
    6,148,012       6,079,430       6,143,871       6,080,840  
                                 
Per Share Data :
                               
Basic
                               
Net earnings   $ 0.20     $ 0.31     $ 0.42     $ 0.57  
                                 
Diluted
                               
Net earnings   $ 0.20     $ 0.31     $ 0.41     $ 0.56  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]  
   
No. of
Shares
   
Weighted Average
Exercise Price
 
Outstanding December 31, 2011
    671,500     $ 10.66  
Granted     194,223       12.62  
Exercised     (74,045 )     9.68  
Lapsed     (86,400 )     12.57  
Cancelled     (23,354 )     12.44  
Outstanding September 30, 2012
    681,924     $ 11.02  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]  
   
No. of
   
Weighted Average
 
   
Shares
   
Exercise Price
 
Outstanding December 31, 2011
    257,424     $ 11.32  
Granted     65,752       13.15  
Exercised     (115,004 )     12.10  
Lapsed     -       -  
Cancelled     (12,396 )     13.15  
Outstanding September 30, 2012
    195,776     $ 11.36  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
     
Three Months Ended September 30,
     
SARS
 
Options
           
Exercise price
         
2012    
N/A
 
$11.72
2011    
N/A
 
$11.95
           
Market price
         
2012    
N/A
 
$11.72
2011    
N/A
 
$11.95
           
Risk free interest rate (1)
         
2012    
N/A
 
0.7%
2011    
N/A
 
1.2%
           
Expected award life (years) (2)
   
N/A
 
5
           
Expected volatility (3)
         
2012    
N/A
 
45.9%
2011    
N/A
 
43.9%
           
Expected dividend yield (4)
         
2012    
N/A
 
4.6%
2011    
N/A
 
4.5%
   
Nine Months Ended September 30,
   
SARS
  Options
             
Exercise price
           
2012  
$13.15
  $11.72
-
$13.15
2011  
$11.24
  $11.10
-
$11.95
             
Market price
           
2012  
$13.15
  $11.72
-
$13.15
2011  
$11.24
  $11.10
-
$11.95
             
Risk free interest rate (1)
           
2012  
0.8%
  0.7%
-
1.9%
2011  
2.3%
  1.2%
-
3.2%
             
Expected award life (years) (2)
 
5
  5
-
10
             
Expected volatility (3)
           
2012  
45.1%
  36.4%
-
45.9%
2011  
43.5%
  35.5%
-
43.9%
             
Expected dividend yield (4)
           
2012  
4.1%
  4.1%
-
4.6%
2011  
4.8%
  4.5%
-
4.9%